Abstract:Diabetes mellitus (DM), is a chronic disorder characterized by impaired glucose homeostasis that results from the loss or dysfunction of pancreatic β-cells leading to type 1 diabetes (T1DM) and type 2 diabetes (T2DM), respectively. Pancreatic β-cells rely to a great degree on their endoplasmic reticulum (ER) to overcome the increased secretary need for insulin biosynthesis and secretion in response to nutrient demand to maintain glucose homeostasis in the body. As a result, β-cells are potentially under ER stress following nutrient levels rise in the circulation for a proper pro-insulin folding mediated by the unfolded protein response (UPR), underscoring the importance of this process to maintain ER homeostasis for normal β-cell function. However, excessive or prolonged increased influx of nascent proinsulin into the ER lumen can exceed the ER capacity leading to pancreatic β-cells ER stress and subsequently to β-cell dysfunction. In mammalian cells, such as β-cells, the ER stress response is primarily regulated by three canonical ER-resident transmembrane proteins: ATF6, IRE1, and PERK/PEK. Each of these proteins generates a transcription factor (ATF4, XBP1s, and ATF6, respectively), which in turn activates the transcription of ER stress-inducible genes. An increasing number of evidence suggests that unresolved or dysregulated ER stress signaling pathways play a pivotal role in β-cell failure leading to insulin secretion defect and diabetes. In this article we first highlight and summarize recent insights on the role of ER stress and its associated signaling mechanisms on β-cell function and diabetes and second how the ER stress pathways could be targeted in vitro during direct differentiation protocols for generation of hPSC-derived pancreatic β-cells to faithfully phenocopy all features of bona fide human β-cells for diabetes therapy or drug screening.

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Living Dangerously: Protective and Harmful ER Stress Responses in Pancreatic β-Cells

Endoplasmic Reticulum (ER) Stress and Its Role in Pancreatic β-Cell Dysfunction and Senescence in Type 2 Diabetes

Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence

Endoplasmic reticulum stress in pancreatic β-cell dysfunctionality and diabetes mellitus: a promising target for generation of functional hPSC-derived β-cells in vitro

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

β cell ER stress and the implications for immunogenicity in type 1 diabetes

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

The Role of Autophagy in Endoplasmic Reticulum Stress-Induced Pancreatic Β Cell Death

Disrupted Endoplasmic Reticulum Ca2+ Handling: A Harβinger of β-Cell Failure

Pancreatic -cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

ER stress and the decline and fall of pancreatic beta cells in type 1 diabetes

Inside the β Cell: Molecular Stress Response Pathways in Diabetes Pathogenesis

Endoplasmic reticulum stress in pancreatic β-cell dysfunction: The potential therapeutic role of dietary flavonoids

Metabolic Stress and Compromised Identity of Pancreatic Beta Cells

Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment

Emerging Therapeutics Targeting Cellular Stress Pathways to Mitigate End-Organ Damage in Type 1 Diabetes

Current Status of Endoplasmic Reticulum Stress in Type II Diabetes

Pancreatic Beta-cell Dysfunction in Type 2 Diabetes